Foundation Fighting Blindness
Foundation Fighting Blindness
Foundation Fighting Blindness
J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
2 minutes Posted May 15, 2025 at 2:07 pm.
0:00
2:35
Download MP3
Show notes
Despite missing the primary endpoint, the treatment improved vision for some patients.